2023 Annual Report and Accounts

Oxford, UK - 30 April 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a quality and innovation-led cell and gene therapy CDMO, gives notice that the 2023 Annual report and accounts is now available on the "Investors" section of the Group's website at www.oxb.com. In accordance with Listing rule 9.6.1, the 2023 Annual report and accounts has also been submitted to the Financial Conduct Authority for publication through the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Further copies of the 2023 Annual report and accounts are available from the Company Secretary, Oxford Biomedica plc, Windrush Court, Transport Way, Oxford, OX4 6LT, United Kingdom (telephone number: +44 (0) 1865 783 000). The Company confirms that, in compliance with DTR 6.3.5(1A), the regulated information required under DTR 6.3.5, is available in unedited full text within the Annual Report available on the National Storage Mechanism and in compliance with DTR 6.3.5(3) is available on the Company's website as noted above.